| Market Cap | ₹235.13 CrSmall Cap |
|---|---|
| P/E TTM | 16.08Sector PE 34.09 |
| Promoter Holding | 68.22%No pledge |
| RSI | 45.68Neutral Zone |
| Metric | Q2-27 | Q1-27 | Q2-26 |
|---|---|---|---|
| Revenue from Operations | 89.2 | 72.4 | 57.8 |
| Other Income | -0.7 | 3.8 | 0.1 |
| Total Income | 88.5 | 76.2 | 57.9 |
| Profit Before Tax | 6.9 | 5.8 | 2.8 |
| Net Profit | 4.3 | 5.7 | 3.8 |
| Operating Margin | 7.8% | 7.6% | 4.8% |
| Net Profit QoQ | -24.6% | ||
| Net Profit YoY | +13.2% | ||
| Adj. Profit QoQ | +280.0% | ||
| Adj. Profit YoY | +181.5% | ||
Key highlights
- Revenue from operations grew 54.3% year-on-year to ₹89.2 crore from ₹57.8 crore
- Operating margins expanded to 7.8% in Q2 FY27, up from 4.8% in the year-ago period
- Profit Before Tax (PBT) reached ₹6.9 crore, a 19% sequential increase from ₹5.8 crore
- Specialty Chemicals segment contributed ₹78.1 crore, representing 87.5% of total turnover
- Net profit stood at ₹4.3 crore, impacted by a ₹1.48 crore deferred tax expense adjustment
Specialty Chemicals Drive Robust Topline Growth
Chembond Material Technologies recorded a substantial 54.3% year-on-year increase in revenue from operations, totaling ₹89.2 crore for the quarter ended September 30, 2026. The Specialty Chemicals segment remains the primary engine of growth, generating ₹78.1 crore during the quarter, while the Animal Health division contributed ₹11.1 crore. This performance reflects the company's steady expansion efforts, following its ₹7.94 crore investment in a 10-acre industrial plot in Karnataka announced in July 2025.
Despite the strong topline momentum, other income turned negative at ₹0.7 crore, contrasting with the ₹3.8 crore gain recorded in the preceding quarter.
Operational Efficiency and Tax Adjustments
Profitability at the operational level showed significant improvement, with Profit Before Tax rising 19% sequentially to ₹6.9 crore. Operating margins expanded to 7.8%, a sharp increase from the 4.8% margin recorded in the same quarter last year. However, consolidated net profit for the quarter moderated to ₹4.3 crore, down from ₹5.7 crore in Q1 FY27.
This sequential dip was primarily attributed to tax dynamics, as the company recognized a deferred tax expense of ₹1.48 crore in the current period, compared to a tax credit in the previous quarter. For the half-year ended September 2026, total comprehensive income reached ₹10.14 crore.
Half-Yearly Segment and Asset Performance
- H1 FY27 revenue from Specialty Chemicals rose to ₹140.13 crore compared to ₹95.74 crore in H1 FY26
- Animal Health segment turnover for the first half reached ₹21.47 crore
- Total consolidated assets increased to ₹235.10 crore as of September 30, 2026
- The company implemented the Chembond ESOP 2025 scheme for eligible employees during the period
- Cash and cash equivalents stood at ₹3.51 crore at the end of the first half
Business Segment Identification
The Group is engaged in the manufacture of Specialty Chemicals, Vitamins & Minerals, Probiotic and Prebiotic Enzymes, as well as Feed Additives and Nutrition products related to Animal Health.
| Date | Announcement | Amount |
|---|---|---|
| 17 Jul 2026 | Q1 FY27 unaudited consolidated revenue from operationsSource: business-standard.com | ₹72.42 Cr |
| 15 May 2026 | Q4 FY26 audited consolidated revenue from operationsSource: BSE filing | ₹71.75 Cr |
| 17 Jan 2026 | Q3 FY26 unaudited consolidated revenue from operationsSource: BSE filing | ₹62.90 Cr |
| 17 Oct 2025 | Q2 FY26 unaudited consolidated total incomeSource: kotakneo.com | ₹57.88 Cr |
| 25 Jul 2025 | Q1 FY26 unaudited consolidated revenue from operationsSource: scanx.trade | ₹57.68 Cr |
| 30 May 2025 | Q4 FY25 audited consolidated revenue from operationsSource: BSE filing | ₹52.21 Cr |
What to watch next
- Reopening of the trading window for dealing in company securities on November 1, 2026
- Operational milestones for the Karnataka capacity expansion project initiated in July 2025
- Announcement of Q3 FY27 financial results in January 2027
| Share price | ₹174.84 |
|---|---|
| Market capitalisation | ₹235.13 Cr |
| Revenue (annual) | ₹250.07 Cr |
| Net profit (annual) | ₹12.89 Cr |
| Revenue (latest quarter) | ₹72.42 Cr+0.92% vs previous quarter |
| Net profit (latest quarter) | ₹5.73 Cr+64.32% vs previous quarter |
| P/E (TTM) | 16.08×Sector 34.09× |
| Promoter holding | 68.22%+0.11% QoQ |
| FII holding | 0.61%Current quarter |
Reference market data from a third-party provider, as of the story. Not a valuation or a recommendation.
Exchange filing by Chembond Material Technologies Limited announcing unaudited financial results for the quarter and half-year ended September 30, 2026. Market figures from a third-party data provider.
